Properly composed treatment and refraining from cigarette consumption can significantly reduce the risk of cardiovascular disease resulting from type 2 diabetes, according to a study published in The New England Journal of Medicine. In some cases, the increased risks could theoretically be eliminated.
Findings could lead to increased screening for PD patients to detect and correct insulin resistance, reports the Journal of Parkinson’s Disease
Pregnant women with type 1 diabetes run a higher risk of having babies with heart defects, especially women with high blood glucose levels during early pregnancy, a study from Karolinska Institutet and the Sahlgrenska Academy in Sweden published in The BMJ shows.
Researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed an oral delivery method that could dramatically transform the way in which diabetics keep their blood sugar levels in check.
New research published in Experimental Physiology has suggested a 6-week CrossFit™ exercise programme can lead to improved control of blood sugar levels and decreased risk of heart disease in people with Type 2 diabetes.
Epidemiological data indicate an explosion of type 2 diabetes cases for women after menopause. What is responsible for that? The surprisingly protective role of oestrogens, highlighted by the fact that a woman undergoing hormone replacement therapy has up to 35% less risks of developing type 2 diabetes than a woman without treatment. By elucidating how oestrogen affects two of the hormones involved in glucose homeostasis, glucagon and GLP1, researchers at the University of Geneva (UNIGE), Switzerland, and at the Geneva University Hospitals (HUG) prove the value of oestrogen supplementation from the onset of menopause.